Erenumab: A Potential Breakthrough in Rosacea Management
Denmark: A nonrandomized controlled trial showed the importance of the calcitonin gene-related peptide (CGRP) pathway in the pathophysiology of erythema and flushing in rosacea. The findings suggested that calcitonin gene-related peptide receptor inhibition holds potential in treating rosacea-associated erythema and flushing. “The study comprising 30 individuals with rosacea-associated flushing and erythema found that subcutaneous injections […]